Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan C Moss

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Current Opinion in Gastroenterology|May 16, 2018
Vitamin D in inflammatory bowel disease: more than just a supplementJohn Gubatan, Alan C Moss
Inflammatory Bowel Diseases|April 7, 2015
Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysisAnita Abhyankar, Alan C Moss
Expert Review of Gastroenterology & Hepatology|March 22, 2014
Current and emerging maintenance therapies for ulcerative colitisAnthony O'Connor, Alan C Moss
Expert Review of Clinical Pharmacology|March 7, 2012
Mesalamine in the treatment and maintenance of remission of ulcerative colitisMaggie Ham, Alan C Moss
Clinical and Experimental Gastroenterology|June 23, 2011
Cause for controversy? Infliximab in the treatment of ulcerative colitis: an updateGarrett Lawlor, Alan C Moss
Clinical Pharmacology : Advances and Applications|August 14, 2012
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamineKavinderjit Nanda, Alan C Moss
Southern Medical Journal|April 3, 2007
Reflux, dyspepsia, and disorders of the foregutAlan C Moss, Ciarán P Kelly
Frontiers in Pharmacology|June 28, 2021
Exosomes in Intestinal InflammationKanchana K Ayyar, Alan C Moss
Frontline Gastroenterology|July 12, 2021
Implications of recurrent SARS-CoV-2 outbreaks for IBD managementJonathan P Segal, Alan C Moss
Inflammatory Bowel Diseases|December 10, 2009
Ocular manifestations in a community-based cohort of patients with inflammatory bowel diseaseDídia Bismara Cury, Alan C Moss
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Current Opinion in Gastroenterology|May 16, 2018
Vitamin D in inflammatory bowel disease: more than just a supplementJohn Gubatan, Alan C Moss
Inflammatory Bowel Diseases|April 7, 2015
Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysisAnita Abhyankar, Alan C Moss
Expert Review of Gastroenterology & Hepatology|March 22, 2014
Current and emerging maintenance therapies for ulcerative colitisAnthony O'Connor, Alan C Moss
Expert Review of Clinical Pharmacology|March 7, 2012
Mesalamine in the treatment and maintenance of remission of ulcerative colitisMaggie Ham, Alan C Moss
Clinical and Experimental Gastroenterology|June 23, 2011
Cause for controversy? Infliximab in the treatment of ulcerative colitis: an updateGarrett Lawlor, Alan C Moss
Clinical Pharmacology : Advances and Applications|August 14, 2012
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamineKavinderjit Nanda, Alan C Moss
Southern Medical Journal|April 3, 2007
Reflux, dyspepsia, and disorders of the foregutAlan C Moss, Ciarán P Kelly
Frontiers in Pharmacology|June 28, 2021
Exosomes in Intestinal InflammationKanchana K Ayyar, Alan C Moss
Frontline Gastroenterology|July 12, 2021
Implications of recurrent SARS-CoV-2 outbreaks for IBD managementJonathan P Segal, Alan C Moss
Inflammatory Bowel Diseases|December 10, 2009
Ocular manifestations in a community-based cohort of patients with inflammatory bowel diseaseDídia Bismara Cury, Alan C Moss
Pageof 14